Tumour-infiltrating CD4 and CD8 T lymphocytes in breast cancer

被引：5

作者：

Gisterek, Iwona ^{[1
]}

Frydecka, Irena ^{[1
]}

Swiatoniowski, Grzegorz ^{[1
]}

Fidler, Sebastian ^{[1
]}

Kornafel, Jan ^{[1
]}

机构：

[1] Med Univ Wroclaw, Dept Oncol, PL-53413 Wroclaw, Poland

来源：

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY | 2008年 / 13卷 / 04期

关键词：

breast cancer; CD4(+); CD8(+);

D O I：

10.1016/S1507-1367(10)60011-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lymphocytes are cells circulating between the blood and tissues. It has been stated that a correlation exists between immune infiltrate and breast cancer. These tumours are infiltrated by T cells, B cells, natural killer cells and macrophages. The infiltrating T cells are of helper (CD4(+)) and cytotoxic (CD8(+)) phenotypes. Specific immunity mediated by cytolytic T lymphocytes is suspected of playing an anticancer role. It is widely known that regional lymph nodes are an important immunological defence or "barrier" against tumour expansion. Some authors have reported that in cancer patients natural killer (NK) cells and CD8(+) T cells are diminished in regional lymph nodes, particularly those involved by the tumour. In the presented study the authors review current knowledge on this problem and the possibility of using successful immunotherapy with monoclonal antibodies for breast cancer.

引用

页码：206 / 209

页数：4

共 30 条

[1] LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER [J].

AALTOMAA, S ;

LIPPONEN, P ;

ESKELINEN, M ;

KOSMA, VM ;

MARIN, S ;

ALHAVA, E ;

SYRJANEN, K .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :859-864

[2] Lymphocyte populations in human lymph nodes.: Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vβ repertoire [J].

Battaglia, A ;

Ferrandina, G ;

Buzzonetti, A ;

Malinconico, P ;

Legge, F ;

Salutari, V ;

Scambia, G ;

Fattorossi, A .

IMMUNOLOGY, 2003, 110 (03) :304-312

[3]

Black M M, 1977, Pathobiol Annu, V7, P213

[4] Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement [J].

Colleoni, M ;

Rotmensz, N ;

Peruzzotti, G ;

Maisonneuve, P ;

Mazzarol, G ;

Pruneri, G ;

Luini, A ;

Intra, M ;

Veronesi, P ;

Galimberti, V ;

Torrisi, R ;

Cardillo, A ;

Goldhirsch, A ;

Viale, G .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1379-1389

[5]

DADMARZ R, 1995, CANCER IMMUNOL IMMUN, V40, P1

[6] An overview of cancer immunotherapy [J].

Davis, ID .

IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (03) :179-195

[7] The innate immune response to tumors and its role in the induction of T-cell immunity [J].

Diefenbach, A ;

Raulet, DH .

IMMUNOLOGICAL REVIEWS, 2002, 188 :9-21

[8] LYMPHOCYTES INFILTRATING HUMAN-BREAST CANCERS LACK K-CELL ACTIVITY AND SHOW LOW-LEVELS OF NK-CELL ACTIVITY [J].

EREMIN, O ;

COOMBS, RRA ;

ASHBY, J .

BRITISH JOURNAL OF CANCER, 1981, 44 (02) :166-176

[9]

FISHER B, 1974, CANCER, V33, P631, DOI 10.1002/1097-0142(197403)33:3<631::AID-CNCR2820330307>3.0.CO

[10]

2-G

← 1 2 3 →